97 related articles for article (PubMed ID: 21378363)
1. Influencing the Wnt signaling pathway in multiple myeloma.
Kim Y; Reifenberger G; Lu D; Endo T; Carson DA; Gast SM; Meschenmoser K; Nowak M; Schmidt-Wolf IG
Anticancer Res; 2011 Feb; 31(2):725-30. PubMed ID: 21378363
[TBL] [Abstract][Full Text] [Related]
2. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.
Kim Y; Schmidt M; Endo T; Lu D; Carson D; Schmidt-Wolf IG
In Vivo; 2011; 25(6):887-93. PubMed ID: 22021681
[TBL] [Abstract][Full Text] [Related]
4. The Wnt /β-catenin signaling pathway in the adult neurogenesis.
Zhang L; Yang X; Yang S; Zhang J
Eur J Neurosci; 2011 Jan; 33(1):1-8. PubMed ID: 21073552
[TBL] [Abstract][Full Text] [Related]
5. New avenues to target Wnt/β-catenin signaling.
Verkaar F; Zaman GJ
Drug Discov Today; 2011 Jan; 16(1-2):35-41. PubMed ID: 21111060
[TBL] [Abstract][Full Text] [Related]
6. Role of the Wnt/beta-catenin network in regulating hematopoiesis.
Wilusz M; Majka M
Arch Immunol Ther Exp (Warsz); 2008; 56(4):257-66. PubMed ID: 18726147
[TBL] [Abstract][Full Text] [Related]
7. Targeting Wnt signaling in colon cancer stem cells.
de Sousa EM; Vermeulen L; Richel D; Medema JP
Clin Cancer Res; 2011 Feb; 17(4):647-53. PubMed ID: 21159886
[TBL] [Abstract][Full Text] [Related]
8. The Wnt signaling pathway and bone metabolism.
Johnson ML; Kamel MA
Curr Opin Rheumatol; 2007 Jul; 19(4):376-82. PubMed ID: 17551370
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
11. Wnt/beta-catenin signaling and cardiogenesis: timing does matter.
Tzahor E
Dev Cell; 2007 Jul; 13(1):10-3. PubMed ID: 17609106
[TBL] [Abstract][Full Text] [Related]
12. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
13. Polyethylenimine-cationized beta-catenin protein transduction activates the Wnt canonical signaling pathway more effectively than cationic lipid-based transduction.
Kitazoe M; Futami J; Nishikawa M; Yamada H; Maeda Y
Biotechnol J; 2010 Apr; 5(4):385-92. PubMed ID: 20235145
[TBL] [Abstract][Full Text] [Related]
14. The Wnt signaling pathway has tumor suppressor properties in retinoblastoma.
Tell S; Yi H; Jockovich ME; Murray TG; Hackam AS
Biochem Biophys Res Commun; 2006 Oct; 349(1):261-9. PubMed ID: 16930536
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
16. On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling.
McDonald SL; Silver AR
Colorectal Dis; 2011 Apr; 13(4):360-9. PubMed ID: 20015264
[TBL] [Abstract][Full Text] [Related]
17. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin in the race to fracture repair: in it to Wnt.
Silkstone D; Hong H; Alman BA
Nat Clin Pract Rheumatol; 2008 Aug; 4(8):413-9. PubMed ID: 18560386
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of Wnt-driven beta-catenin stabilization revealed by quantitative and temporal imaging.
Hannoush RN
PLoS One; 2008; 3(10):e3498. PubMed ID: 18941539
[TBL] [Abstract][Full Text] [Related]
20. Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway.
Schmeel FC; Schmeel LC; Kim Y; Schmidt-Wolf IG
Hematol Oncol; 2014 Dec; 32(4):197-204. PubMed ID: 24470348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
